Multimodal Assessment for Predicting Specific Pathological Substrate in Frontotemporal Lobar Degeneration

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

To establish diagnostic tools to make an accurate clinical and pathological diagnosis of patients with clinical FTLD syndromes

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: t
View:

• Participant must have a reliable study partner who can provide an independent evaluation of functioning.

• Able to read, understand and speak English for neuropsychological testing.

• All subjects must meet one of these diagnostic criteria (A) probable behavioral variant FTD, (B) MRI-supported non-fluent variant PPA; (C) MRI-supported semantic variant PPA and \[18F\]T807 negative (D) probable CBS: using current criteria for CBS(27); (E) PSP: inclusion criteria for PSP are based upon the National Institute of Neurological Disorders and Stroke Society of Progressive Supranuclear Palsy (NINDS-SPSP) (F) FTD-MND

• Control subjects must have a normal neurological exam, a CDR sum of boxes = 0, and MMSE score equal to or greater than 28

Locations
Other Locations
Canada
Toronto Western Hospital, University Health Network
RECRUITING
Toronto
Contact Information
Primary
Cristina Salvo, BSc, MD
cristina.salvo@uhn.ca
416-507-6880
Time Frame
Start Date: 2015-08
Estimated Completion Date: 2026-12
Participants
Target number of participants: 100
Treatments
Progressive supranuclear palsy
Observational Study
Corticobasal syndrome
Observational Study
Behavoral variant FTD
Observational Study
Semantic variant PPA
Observational Study
Non-fluent variant PPA
Observational Study
FTD-motor neuron disease
Observational Study
Healthy controls
Observational Study
Sponsors
Leads: University Health Network, Toronto

This content was sourced from clinicaltrials.gov